Cargando…
Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma
Synovial sarcoma is a soft tissue sarcoma accounting for approximately 1,000 cases per year in the United States. Currently, standard treatment of advanced and metastatic synovial sarcoma is anthracycline-based chemotherapy. While advanced synovial sarcoma is more responsive to chemotherapy compared...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905840/ https://www.ncbi.nlm.nih.gov/pubmed/36761952 http://dx.doi.org/10.3389/fonc.2023.1123464 |